Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for JUNSHI BIO?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2016–2025
Financial statements are reported in CNY, while share price and market cap are quoted in HKD.
Key Multi-Year Facts
- Revenue moved from CN¥3.8M in FY2016 to CN¥2.50B in FY2025 (9-year CAGR +105.9%).
- Net income was negative in FY2016, FY2017, FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024, FY2025.
Latest 5 Fiscal Years
| Fiscal Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (CNY B) | 4.02 | 1.45 | 1.50 | 1.95 | 2.50 |
| YoY | 152.4% | -63.9% | 3.4% | 29.7% | 28.2% |
| Net Income (CNY B) | -0.72 | -2.39 | -2.28 | -1.28 | -0.84 |
| Operating Cash Flow (CNY B) | -0.64 | -1.78 | -2.01 | -1.44 | -0.51 |
| ROE | -10.4% | -27.3% | -27.4% | -19.7% | -14.1% |
| Gross Margin | 68.7% | 63.8% | 55.6% | 74.4% | 79.1% |
| Net Margin | -17.9% | -164.2% | -151.9% | -65.8% | -33.7% |
| Debt-to-Assets | 24.6% | 22.1% | 35.4% | 44.9% | 51.1% |
Show all 10 fiscal years
| Fiscal Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (CNY B) | 0.00 | 0.00 | 0.00 | 0.78 | 1.59 | 4.02 | 1.45 | 1.50 | 1.95 | 2.50 |
| YoY | — | -69.4% | -18.6% | 82886.0% | 105.8% | 152.4% | -63.9% | 3.4% | 29.7% | 28.2% |
| Net Income (CNY B) | -0.13 | -0.32 | -0.72 | -0.74 | -1.67 | -0.72 | -2.39 | -2.28 | -1.28 | -0.84 |
| Operating Cash Flow (CNY B) | -0.19 | -0.35 | -0.51 | -1.19 | -1.50 | -0.64 | -1.78 | -2.01 | -1.44 | -0.51 |
| ROE | -11.6% | -28.5% | -32.3% | -23.6% | -37.7% | -10.4% | -27.3% | -27.4% | -19.7% | -14.1% |
| Gross Margin | 73.8% | 61.1% | 71.4% | 88.3% | 76.6% | 68.7% | 63.8% | 55.6% | 74.4% | 79.1% |
| Net Margin | -3487.4% | -27948.1% | -76703.9% | -96.0% | -104.4% | -17.9% | -164.2% | -151.9% | -65.8% | -33.7% |
| Debt-to-Assets | 2.0% | 8.2% | 22.0% | 32.4% | 27.1% | 24.6% | 22.1% | 35.4% | 44.9% | 51.1% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-05
Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).
Items Flagged for Review
- Alert
-
Alert
Net LossesGoing Concern
FY2025 (2025-12-31) CN¥-0.84B, FY2024 (2024-12-31) CN¥-1.28B
FY2025 (ended 2025-12-31)
-
Watch
High Cash & High DebtSolvency
cash 23.4% of assets, total debt 26.8% of assets
Q3 (2026-09-30)
-
Watch
Profit WarningMaterial Events
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
Dividends
No dividends paid over the trailing 12 months.
Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.
More data: All research reports · Sector leaders · Market hours & holidays.
Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.